Home
News
Create
Screeners
Insights
Jeevan Scientific Technology
65.
66
-1.34
(-2.00%)
Market Cap
₹103.98 Cr
PE Ratio
-23.93
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-2.00%
1M
+5.65%
6M
+57.38%
1Y
+34.16%
5Y
+96.00%
View Company Insights
Latest news about Jeevan Scientific Technology
Jeevan Scientific Promoters Acquire 30L Warrants in Preferential Allotment
7 days ago
Jeevan Scientific Technology's four promoters collectively acquired 30,00,000 convertible warrants through preferential allotment, with Krishna Kishore Kuchipudi leading at 12,00,000 warrants. The acquisitions increase the company's equity capital to ₹19.92 crores and provide potential diluted capital expansion to ₹23.42 crores upon conversion.
Jeevan Scientific Acquires 60% Stake in Naya Pharma for ₹10 Cr
Dec 18, 2025
Jeevan Scientific Technology Limited Shareholders Approve Key Resolutions in EGM
Nov 12, 2025
Jeevan Scientific Technology Reports Net Loss in Q2 Amid Revenue Decline
Nov 12, 2025
Jeevan Scientific Technology Completes US FDA Remote Evaluation Successfully
Nov 08, 2025
More news about Jeevan Scientific Technology
18
Oct 25
Padmaja Private Trust Acquires 7.53% Stake in Jeevan Scientific Technology
Padmaja Private Trust has acquired a substantial 7.53% stake in Jeevan Scientific Technology Limited through preferential allotment of 15 lakh equity shares worth Rs 6 crore. The acquisition, completed on January 2, 2026, triggered SEBI disclosure requirements under Regulation 29(1) as the trust crossed the substantial acquisition threshold. This forms part of the company's successful Rs 30.74 crore capital raising initiative, which will fund expansion plans including API/formulation unit acquisitions and working capital requirements.
15
Oct 25
Jeevan Scientific Technology Unveils Rs. 30.74 Crore Capital Raising Plan
Jeevan Scientific Technology Limited (JSTL) has approved a capital raising plan of Rs. 30.74 crore through convertible warrants and equity shares. The plan includes issuing 35,00,000 convertible warrants at Rs. 40 per warrant and 41,85,000 equity shares at Rs. 40 per share. The warrants will be allotted to both promoters and non-promoters, while the equity shares are exclusively for non-promoters. The company also plans to increase its authorized share capital from Rs. 21 crore to Rs. 25 crore. An Extraordinary General Meeting is scheduled for November 12, 2025, to seek shareholder approval. Post-allotment, promoters' holding is expected to be 38.37%, with public holding at 61.63%.
Jeevan Scientific Technology
65.
66
-
1.
34
(-
2.
00
%)
1 Year Returns:
+34.16%
Industry Peers
Syngene International
630.90
(+
0.
13
%)
Indegene
511.50
(+
0.
12
%)
Suven Life Sciences
151.50
(-
1.
06
%)
Vimta Labs
553.25
(+
0.
68
%)
Take Solutions
43.30
(-
0.
98
%)
Bilcare
72.50
(+
2.
42
%)
Jeevan Scientific Technology
65.66
(-
2.
00
%)
Adeshwar Meditex
18.20
(-
100.
00
%)
Vanta Bioscience
21.50
(-
100.
00
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation